In an expert interview filmed at AAO 2018, Dr Deepinder Dhaliwal discusses the difference between Descemet membrane endothelial keratoplasty (DMEK) and descemetorhexis without endothelial keratoplasty (DWEK) for the treatment of Fuchs’ dystrophy. Dr Dhaliwal explains that in her recent study, corneal oedema was shown to clear on its own, in approximately 7 weeks, after a 4 mm descemetorhexis centred on the visual axis. She also describes that although patients may experience faster results in, terms of vision improvement, with DMEK, this procedure may incur more post-operative complications, such as increased intraocular pressure, when compared to DWEK.
In part 2 of her interview, Dr Deepinder Dhaliwal describes which patients make ideal candidates for descemetorhexis without endothelial keratoplasty (DWEK), and those that are contraindicated. Dr Dhaliwal also explains why some studies may have reported poor outcomes with DWEK. Reasons such as failure to provide rho kinase inhibitors as part of the post-operative management, or those with advanced corneal disease.
1. What are the limitations of the use of Descemet membrane endothelial keratoplasty (DMEK) for patients with Fuchs’ endothelial corneal dystrophy? (0:11)
2. What is the rationale for the use of descemetorhexis without endothelial keratoplasty (DWEK)? (0:50)
3. What were the findings of your recent study comparing the two treatment modalities? (1:47)
4. Which patients are best suited to treatment with descemetorhexis without endothelial keratoplasty (DWEK) and what are the contraindications? (0:11)
5. Why have some studies reported poor outcomes for DWEK? (1:05)
Speaker disclosures: Deepinder Dhaliwal has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Anders Behndig, ESCRS Winter 2022: Individualized Topography-guided Crosslinking for Keratoconus
Prof Anders Behndig (Umeå University Hospital, Umeå, Sweden) discusses the findings from his ongoing study comparing the efficacy, safety and healing phase of two different Customized Remodeled Vision (CuRV) crosslinking protocols for keratoconus. Questions Could you give us a brief overview of customized remodeled vision (CuRV) crosslinking protocols for keratoconus, and their advantages? 00:12-01:25 What […]
Daire Hurley, ESCRS Winter 2022: A Systematic Review and Meta-analysis Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty
Dr Daire Hurley (Mater Misericordiae University Hospital, Dublin, Ireland) discusses the findings from his systematic review and meta-analysis comparing ultrathin descemet stripping automated endothelial keratoplasty and descemet membrane endothelial keratoplasty and explains the impact on clinical decision making for individual patients. Questions Could you give us a brief overview of Ultrathin Descemet Stripping Automated Endothelial […]
Bennie Jeng, AAO 2021: Developments in Keratoconus and Corneal Transplantation
We were delighted to catch up with esteemed Editorial Board member and chair of the AAO annual meeting programme committee, Bennie Jeng (University of Maryland School of Medicine, Baltimore, MD, USA) about recent exciting developments in keratoconus and future directions of corneal transplantation. What have been the most exciting recent developments in keratoconus? (00:16) What […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!